Who owns Acrivon Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ACRV from SEC Form 13F filings across 46 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 46 institutions disclosed 21.4M shares of Acrivon Therapeutics, Inc. worth $38.1M — about 51.2% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
46
13F holders
$38.1M
value, 2026 filers
51.2%
of shares outstanding (21.4M sh)
6
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ACRV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 12.2M | $21.8M | 0.2% | 29.2% | +46.6% |
| 2 | Sands Capital Alternatives, LLC | 2.3M | $4.1M | 0.7% | 5.5% | +7.9% |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 1.2M | $2.1M | 0.0% | 2.8% | +37.7% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 952,008 | $1.7M | 0.0% | 2.3% | +31.9% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 888,130 | $1.6M | 0.0% | 2.1% | 0.0% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 758,863 | $1.4M | 0.0% | 1.8% | +0.1% |
| 7 | TWO SIGMA INVESTMENTS, LP | 641,498 | $1.1M | 0.0% | 1.5% | +64.7% |
| 8 | MARSHALL WACE, LLP | 531,856 | $946,704 | 0.0% | 1.3% | -5.1% |
| 9 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 378,900 | $674,442 | 0.0% | 0.9% | +138.5% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 265,241 | $472,273 | 0.0% | 0.6% | +12.2% |
| 11 | BlackRock, Inc. | 239,112 | $425,620 | 0.0% | 0.6% | +14.4% |
| 12 | GSA CAPITAL PARTNERS LLP | 200,415 | $357,000 | 0.0% | 0.5% | +7.3% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 184,128 | $327,748 | 0.0% | 0.4% | +71.2% |
| 14 | XTX Topco Ltd | 178,239 | $317,265 | 0.0% | 0.4% | +166.5% |
| 15 | JANE STREET GROUP, LLC | 74,648 | $132,874 | 0.0% | 0.2% | -68.9% |
| 16 | NORTHERN TRUST CORP | 67,202 | $119,620 | 0.0% | 0.2% | +37.4% |
| 17 | STATE STREET CORP | 67,145 | $119,518 | 0.0% | 0.2% | 0.0% |
| 18 | UBS Group AG | 43,850 | $78,053 | 0.0% | 0.1% | +26.6% |
| 19 | CITADEL ADVISORS LLCNEW | 41,276 | $73,471 | 0.0% | 0.1% | new |
| 20 | DIMENSIONAL FUND ADVISORS LP | 29,332 | $52,212 | 0.0% | 0.1% | +59.7% |
| 21 | Spark Investment Management LLCNEW | 28,300 | $50,374 | 0.1% | 0.1% | new |
| 22 | PRELUDE CAPITAL MANAGEMENT, LLC | 24,015 | $42,747 | 0.0% | 0.1% | 0.0% |
| 23 | BANK OF AMERICA CORP /DE/ | 16,407 | $29,204 | 0.0% | 0% | -0.6% |
| 24 | Verdad Advisers, LPNEW | 15,054 | $26,796 | 0.0% | 0% | new |
| 25 | GOLDMAN SACHS GROUP INC | 14,920 | $26,558 | 0.0% | 0% | +1.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.